Out with the old, in with the new
New cancer immunotherapy shows promise in treating cancer
Preclinical Research
HCA with 3D models
InSphero-Yokogawa partnership will support drug development research
Talking about a resolution
Data show that OSE-230 can resolve chronic inflammation
Introducing NGM438
NGM438 is an antagonist antibody that inhibits LAIR1
Breathing easier with statins?
InVixa, UC Davis team up to develop inhaled statins for the treatment of COVID-19
Learning new techniques against lymphomas
Researchers have published on a new CAR-T cell therapy using CXCR5
Exosomes to the rescue in cancer
Codiak demonstrates potential of engineered exosomes to stimulate targeted, antitumor immunity
Good news for PolyPEPI-SCoV-2
PepTC reports positive preclinical results for peptide vaccine
Passage makes progress against rare lysosomal storage disease
Preclinical data show injection of optimized AAV vector may correct gangliosidosis
Deep learning for drug design
Metabolite Translator assesses safety of novel compounds
